Health
NAFDAC destroys N22.73bn worth of substandard products in eight months
The National Agency for Food and Drug Administration and Control (NAFDAC) has destroyed unwholesome products valued at approximately N22.73 billion between January and August 2026 as part of efforts to rid the Nigerian market of dangerous, counterfeit and substandard goods.
The destruction was carried out through 22 separate exercises under the agency’s intensified enforcement operations aimed at preventing unsafe products from reaching consumers and endangering public health.
NAFDAC Director-General, Prof. Mojisola Adeyeye, disclosed the figures while presenting the agency’s regulatory achievements at the International Pharmaceutical Regulators Programme (IPRP) Management Committee Meeting held in Prague, Czech Republic, from November 18 to 19, 2026.
According to the presentation, the agency conducted 5,542 enforcement activities within the eight-month period, alongside 213 raids, 821 product seizures and the closure of 179 premises linked to regulatory violations.
The operations also resulted in 52 arrests and 221 sanctions against individuals and businesses found to have breached applicable regulations.
The destruction of products worth N22.73 billion underscores the scale of NAFDAC’s efforts to prevent potentially harmful goods, particularly those failing to meet established safety and quality standards, from circulating in the country.
Beyond its enforcement activities, Adeyeye highlighted improvements in Nigeria’s pharmaceutical regulatory framework, noting that the agency had sustained its World Health Organisation (WHO) Maturity Level 3 status while pursuing advancement to Maturity Level 4.
She attributed the progress partly to the agency’s digital transformation initiatives, which include the Integrated Regulatory Information Management System (IRIMS), i-PMS, GMPi, artificial intelligence-assisted Technical Screening Tools and the revised Med Safety App.
READ ALSO; FCCPC, NAFDAC, SON unite to tackle surge in fake, unwholesome products
The NAFDAC chief also highlighted progress in promoting local pharmaceutical manufacturing through the agency’s 5+5 Policy.
Under the initiative, more than 70 per cent of finished pharmaceutical products covered by the policy and Ceiling 36 are now manufactured locally, according to the presentation.
Adeyeye further outlined the agency’s expanding international regulatory engagements, including technical capacity-building and institutional benchmarking programmes organised for regulatory authorities from Uganda, The Gambia, Mozambique and Côte d’Ivoire.
She said the achievements reflected NAFDAC’s commitment to strengthening regulatory oversight, embracing digital innovation, supporting domestic pharmaceutical production and deepening international cooperation.
The agency’s presentation at the international meeting also highlighted Nigeria’s efforts to improve pharmaceutical regulation and align its systems with global standards.